FDA Reaches $1.25M Deal Over Mislabeled ASP Products

Law360, New York (December 4, 2013, 6:36 PM EST) -- The U.S. Food and Drug Administration said Wednesday it has reached a $1.25 million settlement with Advanced Sterilization Products and two of its executives over allegations that the company knowingly distributed products with inaccurately printed expiration dates to customers.

The FDA took action after learning that ASP, a division of Johnson & Johnson Co.'s subsidiary Ethicon Inc., had been manufacturing and distributing its Sterrad Cyclesure 24 Biological Indicators, which are sterilization monitoring products, despite the products being labeled with inaccurate expiration dates.

"Accurate expiration dates are...
To view the full article, register now.